Sector
Healthcare & Life Sciences
1,855 verified investors state a focus on healthcare & life sciences, and 1,263 transactions in the sector are on record with a disclosed value. Everything below comes from investors’ own disclosures and reported deals.
Across 1,263 recorded transactions. Multiples appear only where the underlying deal disclosed revenue or EBITDA, so they rest on a smaller sample than values.
Activity
Most active acquirers
Buyers appearing most often in recorded transactions in this sector.
Evidence
Recent transactions
A sample of published transactions in the sector.
| Target | Acquirer | Consideration | Date |
|---|---|---|---|
| dne pharma - Business | Navamedic | $27m | 2025-06-23 |
| Kronos Bio | Concentra Biosciences | $35m | 2025-05-01 |
| iCAD | RadNet | $103m | 2025-04-15 |
| LENSAR | Alcon | $430m | 2025-03-24 |
| Mayne Pharma | Cosette Pharmaceuticals | $430m | 2025-02-20 |
| Catapult Health | Teladoc Health | $65m | 2025-02-05 |
| Marinus | Immedica Pharma | $151m | 2024-12-30 |
| G1 Therapeutics | Pharmacosmos | $405m | 2024-08-07 |
| BioVectra | Agilent | $925m | 2024-07-22 |
| Hamilton Thorne | Astorg Partners (PE) | $388m | 2024-07-22 |
| Signature | Pennant | $80m | 2024-07-11 |
| Agile | Insud Pharma | $45m | 2024-06-26 |
Buyers
Who invests here
Verified investors stating a focus on this sector, by strategy.
Investors in this sector that publish what they own:
- +ND Capital 26
- 1517 Fund 12
- 1843 Capital 8
- 369 Growth 12
- 3CC | Third Culture Capital 14
- 5CS Capital 9
- 5square Committed Capital 18
- 645 Ventures 108
- 7G BioVentures 12
- 7wireVentures 34
- 83NORTH 72
- A-Street 13
- ACT Venture Partners 19
- ACVC 19
- AE Industrial Partners LP 33
- AEON Foundry 19
- AGIC Capital 8
- AIF Capital 14
- ALTAMIR 11
- ALTANO CAPITAL 6
- AQC Capital 75
- ARCH Venture 100
- ARTIS Ventures 56
- ATP 6
- ATP 28
- AV8 Ventures 34
- Abingworth 31
- Able 75
- Abundant Venture 4
- AccessTurkey Capital Group 13
Common questions
- What does a healthcare & life sciences company typically sell for?
- Across 1,263 recorded transactions in healthcare & life sciences, the median deal value is $110m, with most deals falling between $30m and $318m. The median EBITDA multiple is 12.5×.
- Who buys healthcare & life sciences companies?
- 1,855 verified investors state a focus on healthcare & life sciences, most commonly venture capital (693), buyout pe (596), growth equity (296). The most frequent acquirers on record include Boston Scientific, Allergan, Ligand Pharmaceuticals.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.